Overcoming barriers in formulating practically insoluble loteprednol etabonate in ophthalmic nanoemulsionEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72025-06-010OA
Characterisation and Stabilisation Mechanisms of Azelaic Acid Nanosuspensions: Insights from a Dual Stabiliser System富马酸纳米悬浮液的表征与稳定机制:来自双稳定剂系统的见解PHARMACEUTICSIF5.52025-03-290OA
Functional ibuprofen-loaded cationic nanoemulsion: Development and optimization for dry eye disease treatmentINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22020-02-0156OAAI
Preparation of in situ hydrogels loaded with azelaic acid nanocrystals and their dermal application performance studyINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22019-05-0153PREAI
Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal modelsEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72018-07-0116PREAI
Lipid/alginate nanoparticle-loaded in situ gelling system tailored for dexamethasone nasal delivery适用于地塞米松鼻腔给药的脂质/藻酸盐纳米粒原位胶凝系统INTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22017-11-0126PREAI
HCE-T cell-based permeability model: A well-maintained or a highly variable barrier phenotype?EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72017-06-0125PREAI
Nanoparticle-mediated interplay of chitosan and melatonin for improved wound epithelialisationCARBOHYDRATE POLYMERSIF12.52016-08-0155PREAI
Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction modelEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72015-07-0139PREAI